Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Odile Fleurot"'
Publikováno v:
American Journal of Psychiatry. 156:610-616
OBJECTIVE: The goal of this placebo-controlled study was to evaluate the efficacy and safety of low doses of amisulpride, an atypical antipsychotic of the benzamide class with high affinity for D2 and D3 dopamine receptors, in the treatment of schizo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bdb4be01204bc91eff850b6b2d4a948
https://doi.org/10.1176/ajp.156.4.610
https://doi.org/10.1176/ajp.156.4.610
Autor:
Odile Fleurot, Stephen Martin, Agnes Giudicelli, Henri Lĵo, Werner Rein, Srinivasa Thirumalai, Joseph Peuskens
Publikováno v:
Current medical research and opinion. 18(6)
To compare the efficacy and safety of the atypical antipsychotics amisulpride and olanzapine in the treatment of acute psychotic exacerbations of schizophrenia.A multinational, double-blind randomised clinical trial.Three hundred and seventy-seven pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6fc225804356e2d7230047053f2fc44
https://pubmed.ncbi.nlm.nih.gov/12442883
https://pubmed.ncbi.nlm.nih.gov/12442883
Autor:
Patrice Jaillon, Brigitte Lecocq, Pierre Boisson, Pierre-Louis Prost, Odile Fleurot, Vincent Lecocq
Publikováno v:
The American journal of cardiology. 66(5)
Bepridil is a calcium antagonist that prolongs the duration of ventricular repolarization, whereas CERM 4205, another calcium antagonist, seems to be devoid of any effect on QT interval. The aim of this study was to compare the effects of bepridil an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31ef803dbdc7d783a43c979f54380e98
https://pubmed.ncbi.nlm.nih.gov/2203243
https://pubmed.ncbi.nlm.nih.gov/2203243